Norwood Receives TGA for Laser Vision Correction Technology

Richard Walmsley, Chief Executive Officer of Norwood Devices, a division of medical technologies group Norwood Abbey, announced the company had received Therapeutic Goods Administration (TGA) approval for its Centurion SES Epikeratome — the key component of Epi-LASIK technology, the next generation of vision correction surgery. TGA approval in Australia follows FDA and European CE Mark approvals in 2004.
Business Wire